DaVita

R1 debuts with $77.5M to advance kidney disease treatment

R1 Therapeutics is debuting with $77.5 million aimed at advancing its first-in-class therapy for patients on dialysis with chronic kidney disease (CKD).

Will Maddox Mar 17, 2026 7:00am

Close-up of Benjamin Franklins eyes peering through hundred dollar bills

The highest-paid medtech CEOs of 2024

Jul 28, 2025 6:00am

Medtronic, DaVita to launch new kidney tech company

May 26, 2022 12:53pm

To incentivize organ donations, DaVita offers staff extra PTO

Feb 14, 2022 11:09am

DaVita taps Baxter's connected dialysis system for home care

May 10, 2021 11:57am

DaVita, Fresenius team up to bring dialysis care into the home

Mar 23, 2021 8:00am